Extensive lentigo maligna clearing with topical imiquimod [6]

Archives of Dermatology

Volumn 139, Issue 7, 2003, Pages 944-945

  Epstein, Ernst ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; AGED; BASAL CELL CARCINOMA; CASE REPORT; CLINICAL TRIAL; CREAM; FEMALE; HUMAN; INFLAMMATION; LETTER; MALIGNANT LENTIGO; MELANOMA; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; FACIAL NEOPLASMS; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 0042809891     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.7.944     Document Type: Letter

References (7)

1. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33:923-936.
2. Anderson KW, Baker SK, Lowe L, Su L, Johnson TM. Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg. 2001;3:202-206.
3. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo malignant melanoma. Dermatol Surg. 1998;24:673-677.
4. Ahmed L, Berth-Jones J. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol. 2000;143:843-845.
5. Steinmann A, Funk JO, Schuler G, von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol. 2000;43:555-557.
6. Bong AB, Bonnekoh B, Franke 1, Schon MP, Ulrich J, Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology. 2002;205:135-138.
7. Ugurel S, Wagner A, Pfohler C, Tilgen W, Reinhold U. Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread. Br J Dermatol. 2002;147:621-624.